PL2026801T3 - Deferazyroks do leczenia dziedzicznej hemochromatozy - Google Patents

Deferazyroks do leczenia dziedzicznej hemochromatozy

Info

Publication number: PL2026801T3
Authority: PL; Poland
Prior art keywords: deferasirox; treatment; hereditary hemochromatosis; hemochromatosis; hereditary
Prior art date: 2006-05-23

Application number

PL07840190T

Other languages

English (en)

Inventor

Hanspeter Nick

Lisa Rojkjaer

Janet Ellen Bodner

Peter Wayne Marks

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-05-23

Filing date

2007-05-21

Publication date

2014-04-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38859061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2026801(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-05-21 Application filed by Novartis Ag filed Critical Novartis Ag

2014-04-30 Publication of PL2026801T3 publication Critical patent/PL2026801T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Epidemiology (AREA)
Obesity (AREA)
Toxicology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL07840190T 2006-05-23 2007-05-21 Deferazyroks do leczenia dziedzicznej hemochromatozy PL2026801T3 (pl)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US74797406P	2006-05-23	2006-05-23
US80304906P	2006-05-24	2006-05-24
US83565806P	2006-08-04	2006-08-04
PCT/US2007/069319 WO2008005624A2 (en)	2006-05-23	2007-05-21	Method of treatment of hereditary hemochromatosis
EP07840190.8A EP2026801B1 (en)	2006-05-23	2007-05-21	Deferasirox for the treatment of hereditary hemochromatosis

Publications (1)

Publication Number	Publication Date
PL2026801T3 true PL2026801T3 (pl)	2014-04-30

Family

ID=38859061

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07840190T PL2026801T3 (pl)	2006-05-23	2007-05-21	Deferazyroks do leczenia dziedzicznej hemochromatozy

Country Status (21)

Country	Link
US (2)	US20110105575A1 (pl)
EP (2)	EP2255805A1 (pl)
JP (1)	JP2009538329A (pl)
KR (1)	KR20080112407A (pl)
AU (1)	AU2007269536B2 (pl)
BR (1)	BRPI0712020A2 (pl)
CA (1)	CA2650433A1 (pl)
CL (1)	CL2007001456A1 (pl)
DK (1)	DK2026801T3 (pl)
ES (1)	ES2440806T3 (pl)
HR (1)	HRP20140096T1 (pl)
IL (1)	IL194659A0 (pl)
MA (1)	MA30432B1 (pl)
MX (1)	MX2008014837A (pl)
NO (1)	NO20084999L (pl)
NZ (1)	NZ572155A (pl)
PL (1)	PL2026801T3 (pl)
PT (1)	PT2026801E (pl)
TN (1)	TNSN08479A1 (pl)
TW (1)	TW200808745A (pl)
WO (1)	WO2008005624A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10694962B2 (en)	2011-06-13	2020-06-30	Cedars-Sinai Medical Center	Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
WO2012174157A1 (en)	2011-06-13	2012-12-20	Cedars-Sinai Medical Center	Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
WO2024011188A1 (en) *	2022-07-07	2024-01-11	Protagonist Therapeutics, Inc.	Combination therapy for treatment of iron overload diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW533205B (en)	1996-06-25	2003-05-21	Novartis Ag	Substituted 3,5-diphenyl-l,2,4-triazoles and their pharmaceutical composition
GB0408078D0 (en) *	2004-04-08	2004-05-12	Novartis Ag	Organic compounds

2007
- 2007-05-21 KR KR1020087028591A patent/KR20080112407A/ko not_active Ceased
- 2007-05-21 EP EP10174063A patent/EP2255805A1/en not_active Withdrawn
- 2007-05-21 NZ NZ572155A patent/NZ572155A/en not_active IP Right Cessation
- 2007-05-21 PL PL07840190T patent/PL2026801T3/pl unknown
- 2007-05-21 HR HRP20140096TT patent/HRP20140096T1/hr unknown
- 2007-05-21 BR BRPI0712020-6A patent/BRPI0712020A2/pt not_active IP Right Cessation
- 2007-05-21 PT PT78401908T patent/PT2026801E/pt unknown
- 2007-05-21 DK DK07840190.8T patent/DK2026801T3/da active
- 2007-05-21 JP JP2009512238A patent/JP2009538329A/ja active Pending
- 2007-05-21 ES ES07840190.8T patent/ES2440806T3/es active Active
- 2007-05-21 US US12/301,777 patent/US20110105575A1/en not_active Abandoned
- 2007-05-21 EP EP07840190.8A patent/EP2026801B1/en active Active
- 2007-05-21 AU AU2007269536A patent/AU2007269536B2/en not_active Ceased
- 2007-05-21 CA CA002650433A patent/CA2650433A1/en not_active Abandoned
- 2007-05-21 WO PCT/US2007/069319 patent/WO2008005624A2/en not_active Ceased
- 2007-05-21 MX MX2008014837A patent/MX2008014837A/es not_active Application Discontinuation
- 2007-05-22 CL CL200701456A patent/CL2007001456A1/es unknown
- 2007-05-22 TW TW096118222A patent/TW200808745A/zh unknown
2008
- 2008-10-07 IL IL194659A patent/IL194659A0/en unknown
- 2008-11-21 TN TNP2008000479A patent/TNSN08479A1/en unknown
- 2008-11-26 MA MA31420A patent/MA30432B1/fr unknown
- 2008-11-28 NO NO20084999A patent/NO20084999L/no not_active Application Discontinuation
2011
- 2011-08-08 US US13/205,164 patent/US20110294861A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2007269536B2 (en)	2011-06-30
US20110294861A1 (en)	2011-12-01
JP2009538329A (ja)	2009-11-05
BRPI0712020A2 (pt)	2011-12-27
DK2026801T3 (da)	2014-01-27
EP2255805A1 (en)	2010-12-01
MX2008014837A (es)	2008-12-01
TNSN08479A1 (en)	2010-04-14
US20110105575A1 (en)	2011-05-05
ES2440806T3 (es)	2014-01-30
NO20084999L (no)	2008-12-23
AU2007269536A1 (en)	2008-01-10
KR20080112407A (ko)	2008-12-24
MA30432B1 (fr)	2009-05-04
NZ572155A (en)	2011-11-25
CA2650433A1 (en)	2008-01-10
PT2026801E (pt)	2014-02-06
HRP20140096T1 (hr)	2014-02-28
TW200808745A (en)	2008-02-16
EP2026801B1 (en)	2013-11-06
CL2007001456A1 (es)	2008-05-16
EP2026801A2 (en)	2009-02-25
WO2008005624A2 (en)	2008-01-10
IL194659A0 (en)	2009-08-03
WO2008005624A3 (en)	2008-03-13

Publication	Publication Date	Title
ZA200810105B (en)	2010-02-24	Means for controlling the progression of myopia
IL183938A0 (en)	2007-10-31	Amino - imidazolones for the inhibition of ?? - becretase
EP2032131A4 (en)	2009-09-02	Methods of Treatment
ZA201001264B (en)	2011-07-27	1-amino-alkylcycohxane derivatives for the treatment of cochleat tinnitus
SI2029155T1 (sl)	2016-06-30	Izboljšano zdravljenje multiplega mieloma
GB0909297D0 (en)	2009-07-15	Composition for the treatment of skin conditions
ZA200708033B (en)	2008-11-26	Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
IL175517A0 (en)	2006-09-05	Processes for preparation of ziprasidone
PL1801108T3 (pl)	2013-04-30	Związki morfolinowe do leczenia stanów zapalnych
IL200032A0 (en)	2010-04-15	Medicament for the treatment of endometriosis
GB0610746D0 (en)	2006-07-12	Method of treatment
IL192933A0 (en)	2009-02-11	Benzoisoindole derivatives for the treatment of pain
ZA200904328B (en)	2010-09-29	Prophylactic or therapeutic agent for alopecia
PT2026801E (pt)	2014-02-06	Deferasorix para o tratamento da hemocromatose
PL1959957T3 (pl)	2012-12-31	Pochodne pirymidyloaminobenzamidu do leczenia neurowłókniakowatości
IL226363A0 (en)	2013-06-27	Compounds and methods for treating cancer
SI2026801T1 (sl)	2014-02-28	Deferasiroks za zdravljenje hereditarne hemokromatoze
ZA200800921B (en)	2009-06-24	Pyrazolone derivatives for the treatment of tuberculosis
ZA200905300B (en)	2010-05-26	Medicament for the treatment of endometriosis
HK1126424A (en)	2009-09-04	Method of treatment of hereditary hemochromatosis
GB0602857D0 (en)	2006-03-22	The treatment of sialorrhoea
GB0624439D0 (en)	2007-01-17	Technique for treatment of gall-and kidney-stones
GB0602858D0 (en)	2006-03-22	The treatment of sialorrhoea
GB0602855D0 (en)	2006-03-22	The Treatment Of Sialorrhoea
GB0625602D0 (en)	2007-01-31	Treatment of sialorrhoea